JPRN-UMIN000022635已完成未知
Comparison of iron-containing marker and non-iron-containing marker for prostate radiotherapy - Comparison of two markers
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50years-old 至 90years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •the patient with hematologic desease
研究者
相似试验
招募中
不适用
Analysis of marker assoriated with iron and inflammation in allogeneic cell transplantation: multicenter prospecitve studyHematologic diseaseJPRN-UMIN000013506Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate of School of Medicine, Yokohama, Japan140
招募中
Unknown
Examining the efficacy of different iron supplements in womeiron deficiencyBlood - AnaemiaACTRN12623000529640Australian Catholic University80
进行中（未招募）
不适用
A non-comparative open-label study of Iron Oligosaccharide in Chronic Kidney Disease patients with a need for parenteral iroEUCTR2007-000765-37-GBPharmacosmos A/S
进行中（未招募）
不适用
A non-comparative open-label study of Iron Oligosaccharide in Chronic Kidney Disease patients with a need for parenteral iroPatients with Chronic kidney disease who are in pre-dialysis or undergoing dialysis (either Peritoneal Dialysis or Haemodialysis), who may be treated with erythropoeisis stimulating agents and have a need for parenteral iron due to either absolute or functional iron deficiency anaemia will be included.MedDRA version: 9.1Level: LLTClassification code 10002062Term: Anaemia iron deficiencyMedDRA version: 9.1Level: LLTClassification code 10018875Term: HaemodialysisMedDRA version: 9.1Level: LLTClassification code 10061105Term: DialysisEUCTR2007-000765-37-DKPharmacosmos A/S
进行中（未招募）
不适用
A non-comparative open-label study of Iron Oligosaccharide in CHF patients with iron deficiency (either absolute or functional) anaemia and a need for parenteral iron.Patients with anaemia and who have a need for parenteral iron due to either absolute or functional iron deficiency anaemia will be included. Patients may receive concomitant Erythropoeisis Stimulating Agents treatment according to hospital standards but this is not a requirement for participation.Patients previous treated with parenteral iron therapy but still needing further Iron who fullfils the inclusion criteria may be switched from an existing parenteral iron treatment.MedDRA version: 9.1Level: LLTClassification code 10002062Term: Anaemia iron deficiencyMedDRA version: 9.1Level: LLTClassification code 10010684Term: Congestive heart failureEUCTR2007-000764-25-SEPharmacosmos A/S